Lima, Josivan Gomes
Valerio, Cynthia Melissa
F. Godoy-Matos, Amélio
Carvalho, Gerson
Dantas, Joana R.
Nunes Salles, João Eduardo
Gerchman, Fernando
Montenegro, Renan
Article History
Received: 20 January 2025
Accepted: 4 October 2025
First Online: 21 November 2025
Declarations
:
: Images of patients used in figures are used with the consent of the patients and/or guardians.
: JS, CMV, JRD, FG and RM have received speaker and consultancy fees from Amryt Pharmaceuticals. CMV is a principal investigator on a Chiesi clinical trial. GC has received a teaching grant and consultancy fees from Amryt Pharmaceuticals. FG has also received consultancy fees from PTC therapeutics, Merck and Novo Nordisk; educational support from Merck and Abbott; and travel grants from Novo Nordisk. All other authors declare no financial conflicts of interest associated with this work. The results presented in this review and commentary are solely based on a thorough analysis of the scientific literature. All authors except GC are members of the Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Brazil.